Clovis Oncology (CLVS) Tops Q3 EPS by 25c

Clovis Oncology (NASDAQ: CLVS) reported Q3 EPS of ($1.70), $0.25 better than the analyst estimate of ($1.95).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• Benchmark on Take-Two's (TTWO) GTV 6 Release: 'we anticipate that the game will not be released within the fiscal year and expect it to launch in fiscal 2026 instead'
• American Express (AXP) down despite beating Q1 estimates on top and bottom lines
• Vail Resorts (MTN) Reports Certain Ski Season Metrics for the Season-to-Date Period Ended April 14